trending Market Intelligence /marketintelligence/en/news-insights/trending/FurGnEpeRhLkpwUX7DNEUw2 content esgSubNav
In This List

Skyline Medical to acquire up to 25% stake in Helomics

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation

Blog

Using Credit Analytics to Avoid Mispricing Insurance Premiums

Blog

Post-Webinar Q&A: Integrating Climate Risks into Credit Risk Portfolios


Skyline Medical to acquire up to 25% stake in Helomics

Skyline Medical Inc. agreed to acquire up to 25% of Helomics Corp., a precision diagnostic company and integrated clinical contract research organization.

Skyline Medical is purchasing preferred stock convertible into 20% of the outstanding Helomics common shares, in exchange for total consideration of 1.1 million newly issued Skyline common shares. Skyline also has the right to convert a previous $500,000 loan to Helomics into an additional 5% equity stake, bringing the total ownership to 25%.

The completion of the purchase is subject to listing of the shares on Nasdaq.

The companies are currently in discussions to form a joint venture.